Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Astra has set the lower boundary of the SPO

4/17/24 ASTR

Uralsib reported for 2023 by IFRS

4/17/24 USBN

Moscow Exchange plans to hold Pre-IPO in Q2

4/17/24 MOEX

Moscow Exchange plans to hold Pre-IPO in Q2

4/17/24 OTCI

Kyuchus field development without benefits is unprofitable

4/17/24 SELG

Polyus sold all shares in Lenzoloto

4/16/24 PLZL

Polyus sold all shares in Lenzoloto

4/16/24 LNZL

Moscow and Beijing have not yet been able to agree on the price of Power of Siberia 2

4/16/24 GAZP

En+ Group invest to JV with CHN Energy about ₽50 billion

4/16/24 ENPG

Transneft reported for Q1 2024 under RAS

4/16/24 TRNFP